Literature DB >> 2504277

Molecular cloning of dog mast cell tryptase and a related protease: structural evidence of a unique mode of serine protease activation.

P Vanderslice1, C S Craik, J A Nadel, G H Caughey.   

Abstract

Mast cell tryptase is a secretory granule associated serine protease with trypsin-like specificity released extracellularly during mast cell degranulation. To determine the full primary structure of the catalytic domain and precursor forms of tryptase and to gain insight into its mode of activation, we cloned cDNAs coding for the complete amino acid sequence of dog mast cell tryptase and a second, possibly related, serine protease. Using RNA from dog mastocytoma cells, we constructed a cDNA library in lambda gt 10. Screening of the library with an oligonucleotide probe based on the N-terminal sequence of tryptase purified from the same cell source allowed us to isolate and sequence overlapping clones coding for dog mast cell tryptase. The tryptase sequence includes the essential residues of the catalytic triad and an aspartic acid at the base of the putative substrate binding pocket that confers P1 Arg and Lys specificity on tryptic serine proteases. The apparent N-terminal signal/activation peptide terminates in a glycine. A glycine in this position has not been observed previously in serine proteases and suggests a novel mode of activation. Additional screening of the library with a trypsinogen cDNA led to the isolation and sequencing of a full-length clone apparently coding for the complete sequence of a second tryptic serine protease (DMP) which is only 53.4% identical with the dog tryptase sequence but which contains an apparent signal/activation peptide also terminating in a glycine. Thus, the proteases encoded by these cloned cDNAs may share a common mode of activation from N-terminally extended precursors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504277     DOI: 10.1021/bi00436a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Cloning and characterization of a second complementary DNA for human tryptase.

Authors:  J S Miller; G Moxley; L B Schwartz
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

Review 2.  Roles of mast cell proteases in airways.

Authors:  J A Nadel
Journal:  Drugs       Date:  1989       Impact factor: 9.546

3.  Corruption of genomic databases with anomalous sequence.

Authors:  E D Lamperti; J M Kittelberger; T F Smith; L Villa-Komaroff
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

Review 4.  Mast cell tryptases and chymases in inflammation and host defense.

Authors:  George H Caughey
Journal:  Immunol Rev       Date:  2007-06       Impact factor: 12.988

5.  Mast cell tryptases: examination of unusual characteristics by multiple sequence alignment and molecular modeling.

Authors:  D A Johnson; G J Barton
Journal:  Protein Sci       Date:  1992-03       Impact factor: 6.725

Review 6.  Mast cell peptidases: chameleons of innate immunity and host defense.

Authors:  Neil N Trivedi; George H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-20       Impact factor: 6.914

Review 7.  Regulation and function of mast cell proteases in inflammation.

Authors:  C Huang; A Sali; R L Stevens
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

Review 8.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

9.  High degree of conservation of the multigene tryptase locus over the past 150-200 million years of mammalian evolution.

Authors:  Jenny M Reimer; Paul B Samollow; Lars Hellman
Journal:  Immunogenetics       Date:  2010-04-10       Impact factor: 2.846

10.  A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I.

Authors:  K Sakai; S Ren; L B Schwartz
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.